REFERENCE
Aton Pharma Inc.ARVO, AOS: Large Study of Lacrisert(Rm) Dry Eye Insert; Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life. Media Release: 4 May 2009. Available from: URL: http://www.atonrx.com
Rights and permissions
About this article
Cite this article
Hydroxypropylcellulose opthalmic insert improves QOL in DES. Pharmacoecon. Outcomes News 579, 12 (2009). https://doi.org/10.2165/00151234-200905790-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905790-00025